DexCom, Inc. (DXCM)
83.03
-1.48
(-1.75%)
USD |
NASDAQ |
Sep 11, 16:00
83.50
+0.47
(+0.57%)
After-Hours: 20:00
DexCom Enterprise Value : 30.79B for Sept. 11, 2026
Enterprise Value Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Enterprise Value Data
| Date | Value |
|---|---|
| September 11, 2026 | 30.79B |
| September 10, 2026 | 31.35B |
| September 09, 2026 | 31.11B |
| September 08, 2026 | 31.35B |
| September 04, 2026 | 32.62B |
| September 03, 2026 | 33.31B |
| September 02, 2026 | 33.30B |
| September 01, 2026 | 33.47B |
| August 31, 2026 | 33.82B |
| August 28, 2026 | 33.73B |
| August 27, 2026 | 33.15B |
| August 26, 2026 | 33.02B |
| August 25, 2026 | 33.10B |
| August 24, 2026 | 33.82B |
| August 21, 2026 | 34.30B |
| August 20, 2026 | 33.50B |
| August 19, 2026 | 33.37B |
| August 18, 2026 | 33.27B |
| August 17, 2026 | 32.95B |
| August 14, 2026 | 33.32B |
| August 13, 2026 | 33.98B |
| August 12, 2026 | 33.72B |
| August 11, 2026 | 33.24B |
| August 10, 2026 | 32.53B |
| August 07, 2026 | 31.44B |
| Date | Value |
|---|---|
| August 06, 2026 | 30.78B |
| August 05, 2026 | 30.65B |
| August 04, 2026 | 32.26B |
| August 03, 2026 | 32.40B |
| July 31, 2026 | 30.95B |
| July 30, 2026 | 27.58B |
| July 29, 2026 | 27.81B |
| July 28, 2026 | 27.70B |
| July 27, 2026 | 27.14B |
| July 24, 2026 | 26.45B |
| July 23, 2026 | 26.05B |
| July 22, 2026 | 26.41B |
| July 21, 2026 | 27.66B |
| July 20, 2026 | 28.02B |
| July 17, 2026 | 28.38B |
| July 16, 2026 | 28.88B |
| July 15, 2026 | 26.90B |
| July 14, 2026 | 27.42B |
| July 13, 2026 | 28.27B |
| July 10, 2026 | 27.74B |
| July 09, 2026 | 27.01B |
| July 08, 2026 | 27.40B |
| July 07, 2026 | 27.22B |
| July 06, 2026 | 26.77B |
| July 02, 2026 | 26.34B |
Enterprise Value Definition
EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.
Enterprise Value Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Enterprise Value Benchmarks
| Abbott Laboratories | 204.07B |
| Insulet Corp. | 9.565B |
| Baxter International, Inc. | 18.98B |
| Stryker Corp. | 117.67B |
| Becton, Dickinson & Co. | 64.39B |
Enterprise Value Related Metrics
| Net Income (Quarterly) | 249.10M |
| Revenue (Quarterly) | 1.308B |
| Total Expenses (Quarterly) | 1.059B |
| EPS Diluted (Quarterly) | 0.6429 |
| Gross Profit Margin (Quarterly) | 63.44% |
| Profit Margin (Quarterly) | 19.04% |
| Earnings Yield | 3.05% |
| Operating Earnings Yield | 3.45% |
| Normalized Earnings Yield | 3.051 |